<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02072564</url>
  </required_header>
  <id_info>
    <org_study_id>DYP-HAB-2010-01</org_study_id>
    <secondary_id>Desarrollos y proyectos en RA</secondary_id>
    <nct_id>NCT02072564</nct_id>
  </id_info>
  <brief_title>Influence of Diet and Lifestyle Factors on the Results of the IVF</brief_title>
  <official_title>Pilot Study on the Influence of the Different Components of the Diet and Different Habits (Tobacco, Alcohol, Physical Exercise, Occupation) Results of IVF-ICSI</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Merck Serono International SA</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is study the possible relationship between various lifestyle habits
      of men and women (age, body mass index, diet, exercise, alcohol, tobacco, coffee, etc..) and
      live birth rate after in vitro fertilization-intracytoplasmatic injection (IVF-ICSI).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      It is a prospective study of couples with primary or secondary infertility, with indication
      for IVF. The main objective is to relate different lifestyle factors (age, BMI, physical
      activity, tobacco consumption, alchol, drugs, work and diet) with reproductive outcomes
      obtained in terms of total oocytes, M II, fertilization and implantation rates pregnancy and
      abortion rates and live birth. It also attempts to correlate the different habits of life in
      men with seminal parameters. For this, both members of the pair separately should answer a
      validated questionnaire before beginning the therapeutic process.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Actual">April 2016</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>9 Months</target_duration>
  <primary_outcome>
    <measure>Live birth rate</measure>
    <time_frame>One year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pregnancy rate</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of mature oocytes</measure>
    <time_frame>Two weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fertilization rate</measure>
    <time_frame>Two weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cancelation rate</measure>
    <time_frame>One month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total dose</measure>
    <time_frame>One month</time_frame>
    <description>Total dose of gonadotrophins needed to stimulate the follicular growth</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Sperm count</measure>
    <time_frame>Two weeks</time_frame>
    <description>Total number of spermatozoa in the seminal and number of spermatozoa/ml</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Abortion rate</measure>
    <time_frame>16 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hyperstimulation rate</measure>
    <time_frame>One month</time_frame>
    <description>Moderate and severe hyperstimulation</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">300</enrollment>
  <condition>Lifestyle Factors</condition>
  <arm_group>
    <arm_group_label>Couples with indication for IVF</arm_group_label>
    <description>Couples with primary or secondary infertility with indication of IVF</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Questionnaire</intervention_name>
    <description>Questionnaire with 100 questions divided into different groups: general data, work, physical activity, character, hobbies, disease and diet.</description>
    <arm_group_label>Couples with indication for IVF</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study sample is obtained from the population of infertile couples who meet the criteria
        for inclusion in a protocol for controlled ovarian stimulation for IVF/ICSI.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Couples who want a pregnancy

          -  Mediterranean or Caucasian Ethnicity.

          -  Infertility to justify treatment with IVF / ICSI-TEI.

          -  First cycle of IVF / ICSI.

          -  Between 18 and 37 years (inclusive)

          -  Presence of one or both ovaries and uterus can withstand embryo implantation and
             pregnancy.

          -  Body mass index (BMI) &lt;40.

          -  Absence of pregnancy before starting ovarian stimulation.

          -  Having given their written consent.

        Exclusion Criteria:

          -  Clinically important disease.

          -  Inclusion in previous cycles of assisted reproduction.

          -  Unexplained vaginal bleeding.

          -  Any contraindication to become pregnant.

          -  Known allergy to preparations of gonadotropins or its excipients.

          -  Patients undergoing oocyte donation cycles -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>37 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Juan José Espinós-Gómez, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital de la Santa Creu i Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <zip>08025</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 24, 2013</study_first_submitted>
  <study_first_submitted_qc>February 25, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 26, 2014</study_first_posted>
  <last_update_submitted>May 10, 2016</last_update_submitted>
  <last_update_submitted_qc>May 10, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 11, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</investigator_affiliation>
    <investigator_full_name>Juan Jose Espinos Gomez</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

